drugset
drugset / Trial / NCT06202456

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

NCT06202456 ↗

Phase 4 Completed 2007 enrolled Shandong New Time Pharmaceutical Co., LTD
Non-randomizedSingle-groupOpen-labelTreatment

Summary

An open Label, Single-arm, Multicenter phase IV study; There was a 2-week screening period and a 12-week / 24-week treatment period

Timeline

Start
2020-05-13
Primary completion
2022-06-09
Completion
2022-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Huazhi Rougan Granule Unknown — —

Indications

No indication recorded.